The 20 Best Familial Hypertrophic Cardiomyopathy Doctors Near Me in Chestnut Hill, MA

Dr. Christine E. Seidman is the director of the Cardiovascular Genetics Program and a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). In addition, she is the Thomas W. Smith Professor of Medicine at Harvard Medical School.She received her medical degree from The George Washington School of Medicine and Health Sciences. She completed an internal medicine residency at The Johns Hopkins Hospital and a cardiology fellowship at Massachusetts General Hospital. Dr. Seidman is board certified in internal medicine and cardiovascular disease. Her clinical interests include cardiovascular medicine and genetics.Dr. Seidman also leads the Seidman Laboratory to elucidate genetic causes for heart disease and other disorders. Notable achievements include the discovery of the first genetic cause of congenital heart malformations. Dr. Seidman promotes collaboration between the Laboratory and the BWH Cardiovascular Genetics Center to translate research discoveries into better diagnostics and improved management strategies. She has authored over 300 peer-reviewed articles and received research funding from the Howard Hughes Medical Institute and National Institutes of Health. Dr. Seidman is rated as an Elite provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Heart Transplant, and Heart Bypass Surgery. Dr. Seidman is board certified in Internal Medicine and Cardiovascular Disease.

Dr. Neal K. Lakdawala is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). He is also an instructor in medicine at Harvard Medical School (HMS).Dr. Lakdawala received his medical degree from The University of Texas HSCSA. He completed a residency and chief residency in internal medicine at Columbia-Presbyterian Medical Center, a clinical and research fellowship in cardiovascular disease at BWH and a master’s degree in epidemiology at the Harvard School of Public Health. Dr. Lakdawala is board certified in internal medicine, cardiovascular disease and advanced heart failure and transplant cardiology.His clinical expertise includes cardiomyopathy, cardiac sarcoidosis, congestive heart failure, cardiovascular genetics and heart transplantation. Dr. Lakdawala’s research and peer-reviewed publications investigate early phenotypes in genetic cardiomyopathy to identify physiology-based therapeutics for heart failure. He has received research funding from the National Institutes of Health’s Heart Failure Network. Dr. Lakdawala is rated as an Elite provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Familial Hypertrophic Cardiomyopathy, Heart Transplant, and Cardiac Ablation. Dr. Lakdawala is board certified in Cardiovascular Disease and Advanced Heart Failure And Transplant Cardiology.

Dr. Calum Archibald MacRae is Vice Chair for Scientific Innovation in the Department of Medicine at Brigham and Women’s Hospital (BWH), a Professor of Medicine at Harvard Medical School, and an expert member of BWH’s Cardiovascular Genetics Program, which comprehensively evaluates, diagnoses and manages care for inherited cardiac disorder patients. In addition, he is a leading investigator at the BWH Genomics Center and an associate professor of medicine at Harvard Medical School.He received his medical degree from University of Edinburgh College of Medicine. He completed two internal medicine residency programs: one at Wellcome Trust Centre for Neuroimaging in London and the other at BWH. He then completed a fellowship in cardiovascular disease at Massachusetts General Hospital. Dr. MacRae is board certified in internal medicine and cardiovascular disease.Dr. MacRae is a cardiologist and geneticist whose clinical interests include investigating new phenotypes and how research findings—including genomics discoveries—can be systematically implemented into clinical care. His research focuses on the biology and genomics of cardiovascular disease, specifically the biological basis of different arrhythmia susceptibilities. He holds five patents, has authored over 160 peer-reviewed publications and received research funding from the National Institutes of Health’s National Human Genome Research Institute. Dr. Macrae is rated as a Distinguished provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), and Cardiac Ablation. Dr. Macrae is board certified in Cardiovascular Disease.

Carolyn Ho is a Cardiologist practicing medicine in Boston,, Massachusetts. Dr. Ho is rated as a Distinguished provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Familial Hypertrophic Cardiomyopathy, Sengers Syndrome, Cardiomyopathy, Atrial Fibrillation, and Pacemaker Implantation.

Dominic Abrams is a Cardiologist practicing medicine in Boston, Massachusetts. Dr. Abrams is rated as a Distinguished provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Long QT Syndrome, Timothy Syndrome, Heart Block, Long QT Syndrome 5, and Cardiac Ablation.

Alfred Buxton is a Cardiac Electrophysiologist practicing medicine in Boston, Massachusetts. Dr. Buxton is rated as an Advanced provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Paroxysmal Supraventricular Tachycardia (PSVT), His Bundle Tachycardia, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Pacemaker Implantation, and Cardiac Ablation. Dr. Buxton is board certified in American Board Of Internal Medicine.

Michael Gavin is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Gavin is rated as an Advanced provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Mitral Valve Regurgitation, Patent Foramen Ovale, Atrial Septal Defect (ASD), Angioplasty, and Pacemaker Implantation. Dr. Gavin is board certified in American Board Of Cardiovascular Disease.

Jenica Upshaw is an Internal Medicine specialist and a Transplant Surgeon practicing medicine in Boston, Massachusetts. She has been practicing medicine for over 18 years. Dr. Upshaw is rated as an Advanced provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, Heart Failure, Heart Transplant, and Patent Foramen Ovale Repair. Dr. Upshaw is board certified in American Board Of Cardiovascular Disease.

Dr. Garrick C. Stewart is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and an instructor in medicine at Harvard Medical School. In addition, he is director of Care New England’s Advanced Heart Failure Program as part of the BWH Cardiovascular Associates at Kent Hospital in Rhode Island.Dr. Stewart received his medical degree from The Johns Hopkins University School of Medicine. He completed his internal medicine residency at BWH; he also completed fellowships in cardiovascular medicine and advanced heart failure at BWH. Dr. Stewart is board certified in advanced heart failure and transplant cardiology, internal medicine and cardiovascular disease.The author of 30 peer-reviewed publications, Dr. Stewart’s research focuses on the physiology of advanced cardiac disease, including inflammatory heart disease, cardiac sarcoidosis and ambulatory advanced heart failure. In collaboration with Dr. Lynne W. Stevenson, he designed and launched the Medical Arm of Mechanically Assisted Circulatory Support (also known as MedaMACS), a nationwide registry of medically managed, ambulatory advanced heart failure patients. Dr. Stewart is rated as an Advanced provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Sarcoidosis, Heart Failure, Cardiomyopathy, Heart Transplant, and Cardiac Ablation. Dr. Stewart is board certified in Cardiovascular Disease and Advanced Heart Failure And Transplant Cardiology.

Dr. Thomas Edward Noonan is a cardiovascular medicine specialist at Brigham and Women’s Hospital. In addition, he is an instructor in medicine at Harvard Medical School. He is also a clinical assistant professor of medicine at The Warren Alpert Medical School of Brown University.Dr. Noonan received his medical degree from Pennsylvania State Hershey College of Medicine. He completed an internal medicine residency at Beth Israel Deaconess Medical Center and a cardiology fellowship at Boston Medical Center. He is board certified in internal medicine and cardiovascular disease.The author of more than four peer-reviewed publications, Dr. Noonan’s research focuses on cardiomyopathy and coronary stenosis. Dr. Noonan’s clinical interests include adult cardiology, cardiac catheterization, and echocardiography. Rhode Island Monthly has listed him as a Top Doctor/Cardiology. Dr. Noonan is rated as an Advanced provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Angina, Coronary Heart Disease, Atherosclerosis, Dilated Cardiomyopathy (DCM), and Pacemaker Implantation.

Patrick T. O'Gara, MD, is the Director of Strategic Planning for the Cardiovascular Division at Brigham and Women’s Hospital, the Watkins Family Distinguished Chair in Cardiology and Professor of Medicine at Harvard Medical School. His clinical activities are focused on patients with valvular heart disease, other structural heart diseases and aortic diseases, although he also maintains a large practice of general cardiology. Since 2001, he has been named annually among the Top Doctors in Boston and the U.S.O'Gara served as President of the American College of Cardiology (ACC) in 2014-15. Additional ACC leadership positions include his roles as Co-Chair of the ACC 2012 Scientific Session program committee, co-directorship of the ACC Board Review Course for Certification and Recertification, and Editor-in-Chief of the ACC Self-Assessment Program (ACCSAP). He served as Chair of the American Heart Association's (AHA's) Council on Clinical Cardiology from 2003-2005 and as the inaugural Editor of Heart Insight magazine from 2006 to 2011. In 2011, he received the Paul Dudley White Award from the Boston Division of the AHA Founder's Affiliate and has also been recognized with the Laennec Master Clinician Award (2011) and the Laennec Clinician Educator Award (2012). O'Gara was Chair of the writing committee for the 2013 ACC/AHA Guideline for the Management of Patients with ST-Elevation MI and has participated in several other guideline, expert consensus, scientific advisory and appropriate use criteria writing groups.He is currently the Vice-Chair for the AHA/ACC Task Force on Clinical Practice Guidelines. He is also the Steering Committee Co-Chair of the National Heart, Lung, and Blood Institute's Cardiothoracic Surgery Network, which has completed 3 groundbreaking, randomized controlled trials in cardiac surgery. O’Gara serves as Associate Editor for JAMA Cardiology and is a member of the Editorial Boards of the Journal of the American College of Cardiology and Circulation. He has lectured widely and authored or co-authored over 250 original manuscripts, chapters, critical reviews, statements and editorials. Dr. O'gara is rated as an Advanced provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Mitral Valve Regurgitation, Bicuspid Aortic Valve, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). Dr. O'gara is board certified in Internal Medicine.

Dr. Paul Zei is a Cardiac Electrophysiologist and Cardiologist at Brigham and Women’s Hospital. He is Director of the BWH Comprehensive Atrial Fibrillation Program, with a faculty appointment at Harvard Medical School.Dr. Zei earned his medical degree and a PhD at Stanford University. He then completed Internal Medicine Internship and Residency, Cardiology Fellowship, and Cardiac Electrophysiology Fellowship training at BWH. After briefly serving on the faculty at BWH, he moved to Stanford University, where he spent eleven years as a faculty member in Cardiology and Cardiac Electrophysiology. At Stanford, Dr. Zei developed a program in complex ablation, a research program in technology innovation, and he also served as the Director of Outpatient Cardiology and ECG services. Dr. Zei then returned to Boston to re-join the faculty at BWH and Harvard Medical School.Dr. Zei’s clinical interests focus on management of complex arrhythmias, with an emphasis on atrial fibrillation, catheter ablation of complex arrhythmias, and device implantation. In his role as Director of BWH’s Comprehensive Atrial Fibrillation Program, Dr. Zei brings together a multi-disciplinary approach to the management of patients with Atrial Fibrillation and leads several research initiatives to better understand and treat patients with this condition. Dr. Zei’s research interests are in understanding the basic underlying mechanisms of cardiac arrhythmias and developing new technologies to treat patients with cardiac arrhythmias. Dr. Zei is rated as an Advanced provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Ventricular Tachycardia, Arrhythmias, Cardiac Ablation, and Pacemaker Implantation. Dr. Zei is board certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology.

Frederick Basilico is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Basilico is rated as an Advanced provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Angina, Arrhythmias, and Coronary Heart Disease. Dr. Basilico is board certified in American Board Of Internal Medicine.

Steve Colan is a Pediatric Cardiologist practicing medicine in Boston, Massachusetts. Dr. Colan is rated as an Advanced provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Dilated Cardiomyopathy (DCM), Heart Transplant, and Heart Valve Repair.

Peter Zimetbaum is a Cardiac Electrophysiologist practicing medicine in Boston, Massachusetts. Dr. Zimetbaum is rated as an Advanced provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Arrhythmias, Cardiomyopathy, Pacemaker Implantation, and Cardiac Ablation. Dr. Zimetbaum is board certified in American Board Of Internal Medicine.

James Chang is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Chang is rated as an Advanced provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Mitral Valve Regurgitation, Heart Failure, Cardiomyopathy, Transcatheter Aortic Valve Replacement (TAVR), and Pacemaker Implantation. Dr. Chang is board certified in American Board Of Internal Medicine.

Warren Manning is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Manning is rated as an Advanced provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Mitral Valve Regurgitation, Pacemaker Implantation, and Cardiac Ablation. Dr. Manning is board certified in American Board Of Cardiovascular Disease.

Charles Haffajee is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Haffajee is rated as an Advanced provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Arrhythmias, Familial Progressive Cardiac Conduction Defect, Pacemaker Implantation, and Cardiac Ablation. Dr. Haffajee is board certified in American Board Of Internal Medicine.

Usman Tahir is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Tahir is rated as an Advanced provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Familial Hypertrophic Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Subvalvular Aortic Stenosis, and Sengers Syndrome. Dr. Tahir is board certified in American Board Of Cardiovascular Disease.

Eli Gelfand is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Gelfand is rated as an Advanced provider by MediFind in the treatment of Familial Hypertrophic Cardiomyopathy. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Mitral Valve Regurgitation, Necrosis, Heart Attack, Heart Failure with Preserved Ejection Fraction (HFpEF), and Pacemaker Implantation. Dr. Gelfand is board certified in American Board Of Internal Medicine.